EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A 3‐Month Follow‐Up Pilot Study on Accelerated Intermittent Theta Burst Stimulation for Bipolar Depression

Daan Neuteboom iD, Urmi Pahladsingh, Martijn C Steinbach, Marjan C Ploegaert, Jasper B Zantvoord iD, Anja Lok, Lieuwe de Haan, Karel W F Scheepstra iD

Bipolar Disorders · 2026-08 · 28 (5)

DOI: 10.1111/bdi.70148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bipolar Disorders, online erschienen am 02.07.2026. Verfasst von Daan Neuteboom und 7 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, University of Amsterdam, Adult Psychiatry, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Bipolar Disorder, Transcranial Magnetic Stimulation, Theta Rhythm, Depressive Disorder, Treatment-Resistant. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 25% of patients with bipolar disorder are reported to have treatment‐resistant bipolar depression (TRBD). Accelerated intermittent Theta Burst Stimulation (aiTBS) is an innovative form of repetitive transcranial magnetic stimulation (rTMS), delivering bursts of stimulation at theta wave frequencies, which are believed to enhance synaptic plasticity. This pilot study aimed to explore the safety, tolerability, and preliminary efficacy of aiTBS in individuals with treatment‐resistant bipolar depression (TRBD).

Methods

This open‐label pilot study (registered at Overview of Medical Research in the Netherlands (OMON), NL‐OMON53634), conducted between July 2023 and September 2024, included patients aged 43–64 years who were diagnosed with bipolar I or II and were experiencing a current moderate‐to‐severe depressive episode. Patients were required to have treatment‐refractory symptoms according to the Hidalgo‐Mazzei criteria. All patients were receiving antidepressant medication. Patients received eight daily sessions of intermittent Theta Burst Stimulation (iTBS) over five consecutive days, with 50‐min intervals between sessions. Stimulation targeted the left dorsolateral prefrontal cortex (DLPFC) using the BeamF3 targeting method. Outcomes included safety, tolerability, and efficacy and were assessed at day 3, day 5, week 2, week 4 and week 12 post‐treatment. Safety was assessed by documentation of serious adverse events (SAEs) and adverse events (AEs); tolerability was evaluated based on reported side effects. Efficacy was measured by the mean reduction in depression symptoms using the 17‐item Hamilton Depression Rating Scale (HDRS‐17).

Results

Eight patients were recruited, all of whom completed the treatment course. aiTBS was well tolerated and no SAEs occurred during the treatment week or during follow‐up. The most frequently reported AEs were discomfort at the stimulation site and fatigue (87.5%). Although one patient experienced hypomanic symptoms (YMRS = 13) at the 3‐month follow‐up visit, this was considered unrelated to the study treatment due to the timing of onset, and because several significant psychosocial stressors were identified in the patient's life during that period. Mean HDRS scores decreased from 22.9 (SD = 4.4) at baseline to 16.6 (SD = 4.2) on day 3 of treatment (difference = 6.3 (95% CI, 1.6–10.9); 27.3% improvement, p = 0.01), 12.8 (SD = 4.1) on day 5 (difference = 10.1 (95% CI, 2.2–18.1); 44.3%, p = 0.02), 11.1 (SD = 3.8) at week 2 (difference = 11.8 (95% CI, 4.5–19.0); 51.4%, p = 0.004) and 13.5 (SD = 3.9) at week 4 (difference = 9.4 (95% CI, 1.0–17.7); 41.0% improvement, p = 0.03). At month 3, the mean HDRS score was 13.7 (SD = 6.9, difference compared to baseline = 9.1 (95% CI, −3.0 to 21.3); 40.0% improvement, p = 0.2).

Conclusion

This pilot study extends prior evidence suggesting the antidepressant effects, safety, and tolerability of aiTBS in patients with TRBD; however, its durability may be limited. We recommend that future RCTs investigate relapse prevention following acute aiTBS and determine the optimal strategy for maintaining antidepressant effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderTranscranial Magnetic StimulationTheta RhythmDepressive Disorder, Treatment-ResistantDorsolateral Prefrontal CortexOutcome Assessment, Health CareHumansPilot ProjectsMiddle AgedAdultFemaleMaleFollow-Up Studies

Stichwörter der Autor:innen

accelerated intermittent theta burst stimulation (aiTBS)bipolar disorder (BD)non‐invasive brain stimulation (NIBS)repetitive transcranial magnetic stimulation (rTMS)treatment resistant bipolar depression (TRBD)

Autor:innen und Institutionen

  • Amsterdam UMC, University of Amsterdam, Adult Psychiatry, Amsterdam, the Netherlands.
  • Amsterdam Neuroscience, Mood, Anxiety, Psychosis, Stress & Sleep, Amsterdam, the Netherlands.
  • Parnassia Group, the Hague, the Netherlands.
  • Center for Urban Mental Health, University of Amsterdam, Amsterdam, the Netherlands.
  • Neuroimmunology Research Group, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands.

ORCID-Profile: Daan Neuteboom, Jasper B Zantvoord, Karel W F Scheepstra

Zitieren

APA

Neuteboom, D., Pahladsingh, U., Steinbach, M. C., Ploegaert, M. C., Zantvoord, J. B., Lok, A., de Haan, L., & Scheepstra, K. W. F. (2026). A 3‐Month Follow‐Up Pilot Study on Accelerated Intermittent Theta Burst Stimulation for Bipolar Depression. Bipolar Disorders, 28(5). https://doi.org/10.1111/bdi.70148

Vancouver

Neuteboom D, Pahladsingh U, Steinbach MC, Ploegaert MC, Zantvoord JB, Lok A, et al. A 3‐Month Follow‐Up Pilot Study on Accelerated Intermittent Theta Burst Stimulation for Bipolar Depression. Bipolar Disorders. 2026;28(5). doi:10.1111/bdi.70148

BibTeX
@article{Neuteboom2026,
  author = {Neuteboom, Daan and Pahladsingh, Urmi and Steinbach, Martijn C and Ploegaert, Marjan C and Zantvoord, Jasper B and Lok, Anja and de Haan, Lieuwe and Scheepstra, Karel W F},
  title = {A 3‐Month Follow‐Up Pilot Study on Accelerated Intermittent Theta Burst Stimulation for Bipolar Depression},
  journal = {Bipolar Disorders},
  year = {2026},
  volume = {28},
  number = {5},
  doi = {10.1111/bdi.70148}
}
Kostenlos starten →